These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7425608)

  • 1. Combined effect of amphotericin B and rifampin on Candida species.
    Edwards JE; Morrison J; Henderson DK; Montgomerie JZ
    Antimicrob Agents Chemother; 1980 Mar; 17(3):484-7. PubMed ID: 7425608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic action of amphotericin B and rifampin against Candida species.
    Beggs WH; Sarosi GA; Walker MI
    J Infect Dis; 1976 Feb; 133(2):206-9. PubMed ID: 1245767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
    Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
    Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amphotericin B alone or in combination with rifampicin on phagocytosis of Candida species by human polymorphonuclear leukocytes.
    Schaumann RF; Shah PM
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):753-8. PubMed ID: 1297891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of amphotericin B and rifampin against Rhizopus species.
    Christenson JC; Shalit I; Welch DF; Guruswamy A; Marks MI
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1775-8. PubMed ID: 3435124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.
    Seidenfeld SM; Cooper BH; Smith JW; Luby JP; Mackowiak PA
    J Infect Dis; 1983 Jan; 147(1):116-9. PubMed ID: 6822746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.
    Fujita NK; Edwards JE
    Antimicrob Agents Chemother; 1981 Jan; 19(1):196-8. PubMed ID: 7018384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the in vitro activity of amphotericin B against the biofilms of non-albicans Candida spp. by rifampicin and doxycycline.
    El-Azizi M
    J Med Microbiol; 2007 May; 56(Pt 5):645-649. PubMed ID: 17446287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro combination therapy with isavuconazole against Candida spp.
    Katragkou A; McCarthy M; Meletiadis J; Hussain K; Moradi PW; Strauss GE; Myint KL; Zaw MH; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ; Petraitis V
    Med Mycol; 2017 Nov; 55(8):859-868. PubMed ID: 28204571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR; Young VM; Morris MJ; Schimpff SC
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
    Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
    FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of chlorpromazine on Candida species.
    Wood NC; Nugent KM
    Antimicrob Agents Chemother; 1985 May; 27(5):692-4. PubMed ID: 4015066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
    J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
    Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
    Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species.
    Tabbene O; Di Grazia A; Azaiez S; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML
    FEMS Yeast Res; 2015 Jun; 15(4):fov022. PubMed ID: 25956541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].
    Yalçin B; Kalkanci A; Gürelik F; Fidan I; Kustimur S; Ozdek S
    Mikrobiyol Bul; 2010 Jan; 44(1):65-70. PubMed ID: 20455400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.